IP Library › Granted Patent US 8,609,397
Granted Patent B2
US 8,609,397 · App. 11/631,872 · Granted Dec 17, 2013

Method for preserving a microorganism

Inventor: Kenichi Higashiyama (Kobe, JP)
Assignee: Nippon Suisan Kaisha, Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,609,397
App. No.
11/631,872
Granted
Dec 17, 2013
Kind
B2
Abstract

A method for preservation of a microorganism capable of microbial production of a polyunsaturated fatty acid or a compound comprising a polyunsaturated fatty acid as a constituent fatty acid, which method comprises: (a) forming spores in a spore-forming medium at pH 4-7 containing a nutrient source comprising an inorganic salt and a saccharide; (b) suspending the spores obtained in (a) in sterilized water, or sterilized water containing a surfactant and/or an inorganic salt to prepare a spore suspension, and adding a cryoprotectant at 5-15% to prepare a cryopreserving spore suspension; and (c) preserving the cryopreserving spore suspension obtained in (b) at between −100° C. and −20° C.

Claims (12)

1. A method for preservation of a spore-forming microorganism capable of microbial production of a polyunsaturated fatty acid or a compound comprising a polyunsaturated fatty acid as a constituent fatty acid, wherein the spore-forming microorganism is Mortierella alpina , which method comprises:

(a) culturing the microorganism in a spore-forming medium at pH 4-7 containing a nutrient source comprising an inorganic salt and a saccharide, wherein the microorganism forms spores;

(b) suspending the spores obtained in (a) in sterilized water, or sterilized water containing a surfactant and/or an inorganic salt to prepare a spore suspension, and adding a cryoprotectant at 5-15% to prepare a cryopreserving spore suspension; and

(c) preserving the cryopreserving spore suspension obtained in (b) at between −100° C. and −20° C.

2. A method according to claim 1 , wherein said inorganic salt is at least one type of inorganic salt selected from the group consisting of sodium nitrate, dipotassium hydrogen phosphate, magnesium sulfate, potassium chloride and iron (II) sulfate.

3. A method according to claim 1 , characterized in that said spore-forming medium is Czapek agar medium or Czapek-Dox agar medium adjusted to a pH of 4-7 with hydrochloric acid and/or sulfuric acid.

4. A method according to claim 1 , characterized in that said cryoprotectant is glycerin.

5. A method for preservation of a microorganism according to claim 1 , wherein the microorganism is capable of producing a triglyceride comprising a polyunsaturated fatty acid as a constituent fatty acid or a phospholipid comprising a polyunsaturated fatty acid as a constituent fatty acid.

6. A method for preservation of a microorganism according to claim 1 , wherein the microorganism is capable of producing an ω6 unsaturated fatty acid, ω3 polyunsaturated fatty acid, ω9 polyunsaturated fatty acid, or a combination thereof, or a compound comprising an ω6 unsaturated fatty acid, ω3 polyunsaturated fatty acid, ω9 polyunsaturated fatty acid, or a combination thereof.

7. A method for preservation of a microorganism according to claim 6 , wherein the ω6 unsaturated fatty acid is 9,12-octadecadienoic acid (linoleic acid) 18:2ω6, 6,9,12-octadecatrienoic acid (γ-linolenic acid) 18:3ω6, 8,11,14-eicosatrienoic acid (dihomo-γ-linolenic acid) 20:3ω6, 5,8,11,14-eicosatetraenoic acid (arachidonic acid) 20:4ω6, 7,10,13,16-docosatetraenoic acid 22:4ω6 or 4,7,10,13,16-docosapentaenoic acid 22:5ω6.

8. A method for preservation of a microorganism according to claim 6 , wherein the ω3 unsaturated fatty acid is 9,12,15-octadecatrienoic acid α-linolenic acid) 18:3ω3, 6,9,12,15-octadecatetraenoic acid (stearidonic acid) 18:4ω3, 11,14,17-eicosatrienoic acid (dihomo-α-linolenic acid) 20:3ω3, 8,11,14,17-eicosatetraenoic acid 20:4ω3, 5,8,11,14,17-eicosapentaenoic acid 20:5ω3, 7,10,13,16,19-docosapentaenoic acid 22:5ω3 or 4,7,10,13,16,19-docosahexaenoic acid 22:6ω3.

9. A method for preservation of a microorganism according to claim 6 , wherein the ω9 unsaturated fatty acid is 6,9-octadecadienoic acid 18:2ω9, 8,11-eicosadienoic acid 20:2ω9 or 5,8,11-eicosatrienoic acid (Mead acid) 20:3ω9.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2010
From: SUNTORY HOLDINGS LIMITED
To: NIPPON SUISAN KAISHA, LTD.
Reel/Frame 024080/0360 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2009
From: SUNTORY LIMITED
To: SUNTORY HOLDINGS LIMITED
Reel/Frame 023049/0707 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2007
From: HIGASHIYAMA, KENICHI
To: SUNTORY LIMITED
Reel/Frame 018776/0760 →
Priority Claims (1)
JP 2004-235551 · Aug 12, 2004 · national
Continuity (1)
Related Publication 20080038789A1 · Feb 14, 2008